HOMEVULNERABILITIESCVE-2026-10850
MEDIUM

CVE-2026-10850

CWE-79Published: June 17, 2026· Updated: Jun 23, 2026

5.4
CVSS v3.1

Official Description

Plane CE 1.3.1 allows a low-privileged project member to submit arbitrary HTML/JS in the description_html field when creating an intake work item through the API v1 intake endpoint.

NVD Source

Technical Analysis

CVE-2026-10850 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

Exploitation requires low privileges, which limits the exposure to scenarios where an attacker has already gained initial access.

The vulnerability has a "Changed" scope, meaning successful exploitation can impact components beyond the vulnerable component itself — such as the host operating system or adjacent services.

From a weakness classification perspective (CWE-79): Cross-site scripting (XSS) vulnerabilities allow attackers to inject malicious scripts into web pages viewed by other users.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.Low
User InteractionRequired
ScopeChanged
Impact
ConfidentialityLow
IntegrityLow
AvailabilityNone
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Affected Vendors & Products

plane1 product
plane
Source: NVD CPE · 1 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (3)

Quick Facts

CVE IDCVE-2026-10850
CVSS Score5.4 / 10
SeverityMEDIUM
WeaknessCWE-79
CISA KEVNo
Affected1 vendor
PublishedJun 17, 2026

Related CVEs (CWE-79)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2026-10850 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.